Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
Published on Thu 20 Feb 2025 10:17:29 UTC
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Compliancy Group, healthcare compliance tracking and management software, has been named toG2's 2025 Best Software Awards on the Healthcare Software Products list. G2's annual Best Software Awards rank the world's best software companies and products based on authentic, timely reviews from real users.
Published on Thu 20 Feb 2025 10:17:22 UTC
OSLO, Norway, Feb. 20, 2025 /PRNewswire/ -- In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events:
Published on Thu 20 Feb 2025 10:17:21 UTC
SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year2024 ended December 31, 2024, before the U.S. market opens on Thursday, March 20, 2025.
Published on Thu 20 Feb 2025 10:15:01 UTC
Global Financial Market Review (GFM) is a dedicated online news aggregation portal specializing in financial market news and industry updates. It combines original editorials with curated content from global news providers, reaching over 14 million readers annually. With a focus on reliability and depth, GFM has positioned itself as a trusted source in the financial sector, boasting a strong social media presence with over 180,000 Twitter followers.
Published on Thu 20 Feb 2025 10:13:18 UTC
Desert Senita
Published on Thu 20 Feb 2025 10:11:10 UTC
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong KongPharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving hundreds of millions of consumers. This partnership aims to revolutionize cross-border logistics services and enhance the overall customer experience.
Published on Thu 20 Feb 2025 7:56:15 UTC
The spinal cord injury market is expected to experience steady growth, with a strong CAGR of 15.4% forecast from 2024 to 2034. This growth across the 7MM will be propelled by the introduction of innovative therapies such as KP-100IT, Neuro-Cells, Elezanumab (ABT-555), and MT-3921.
Published on Thu 20 Feb 2025 7:56:14 UTC
Continan con sus esfuerzos para aumentar el acceso aopciones de tratamiento con insulina
Published on Thu 20 Feb 2025 7:56:11 UTC
MINNEAPOLIS, Feb. 19, 2025 /PRNewswire/ -- TheAmerican Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain. The systematic review is published in the February 12, 2025, online issue of Neurology. It updates a 2007 assessment by the AAN.
Published on Thu 20 Feb 2025 7:56:09 UTC
New PSA highlights the impacts of Adverse Childhood Experiences (ACEs) and toxic stress, offering tools to help Californians heal and build resilience
Published on Thu 20 Feb 2025 7:56:08 UTC
SAN MATEO, Calif., Feb. 19, 2025 /PRNewswire/ --Peninsula Family Service (PFS), a leading nonprofit organization dedicated to empowering individuals and families across the Peninsula, is proud to announce a year-long celebration marking its 75th anniversary. Since 1950, PFS has been a trusted community partner, providing essential services that enable community members to lead healthy, stable lives.
Published on Thu 20 Feb 2025 7:56:04 UTC
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I), today announced a licensing agreement with the University of Alabama at Birmingham (UAB) to support their research in B cell development.
Published on Thu 20 Feb 2025 7:55:40 UTC
CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ -- OpenEvidence, the fastest-growing platform for doctors in history, has closed a Series A with Sequoia Capital at a $1 billion valuation. This milestone marks OpenEvidence's first institutional investment and brings the company's total capital raised to over $100 million.
Published on Thu 20 Feb 2025 7:55:37 UTC
TAIPEI, Feb. 19, 2025 /PRNewswire/ -- NaviFUS Corp. is dedicated to advancing non-invasive treatments for complex brain disorders, a challenging area in medical innovation. By using ultrasound technology for both diagnosis and therapy, NaviFUS exceeds the signal processing capabilities of traditional medical devices. This is made possible by Taiwan's advanced chip technology, which positions NaviFUS as a global leader in focused ultrasound-based treatment solutions. This cutting-edge technology integrates ICT capabilities into high-end medical devices seamlessly.
Published on Thu 20 Feb 2025 7:55:36 UTC
TAIPEI, Feb. 20, 2025 /PRNewswire/ -- NaviFUS Corp. is revolutionizing brain disorder treatments through ultrasound-based solutions, leveraging Taiwan's advanced chip technology. By integrating ICT capabilities into high-end medical devices, NaviFUS enhances signal processing beyond traditional medical devices, positioning itself as a global leader in focused ultrasound treatments.
Published on Thu 20 Feb 2025 7:55:35 UTC
TAIPEI, 20 fvrier 2025 /PRNewswire/ -- NaviFUS Corp. rvolutionne les traitements des troubles crbraux grce des solutions bases sur les ultrasons, en tirant parti de la technologie avance des puces de Tawan. En intgrant des capacits TIC dans des appareils mdicaux haut de gamme, NaviFUS amliore le traitement des signaux au-del des appareils mdicaux traditionnels, se positionnant ainsi comme un leader mondial dans les traitements par ultrasons focaliss.
Published on Thu 20 Feb 2025 7:55:33 UTC
TAIPEI, 20. Februar 2025 /PRNewswire/ -- NaviFUS Corp. revolutioniert die Behandlung von Hirnleistungsstrungen durch ultraschallbasierte Lsungen und nutzt dabei die fortschrittliche Chiptechnologie Taiwans. Durch die Integration von IKT-Funktionen in medizinische High-End-Gerte verbessert NaviFUS die Signalverarbeitung ber die herkmmlichen medizinischen Gerte hinaus und positioniert sich als weltweit fhrendes Unternehmen fr fokussierte Ultraschallbehandlungen.
Published on Thu 20 Feb 2025 7:53:18 UTC
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic and its partner Bristol Myers Squibb (NYSE: BMY) have received clearance from the U.S. Federal Trade Commission (FTC) for BioArctic to out-license its PyroGlutamate-amyloid-beta (PyroGlu-A) antibody program to Bristol Myers Squibb.Closing of the agreement has been completed and BioArctic will receive an upfront payment of USD 100 million.
Published on Thu 20 Feb 2025 7:53:17 UTC
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic and its partner Bristol Myers Squibb (NYSE: BMY) have received clearance from the U.S. Federal Trade Commission (FTC) for BioArctic to out-license its PyroGlutamate-amyloid-beta (PyroGlu-A) antibody program to Bristol Myers Squibb.Closing of the agreement has been completed and BioArctic will receive an upfront payment of USD 100 million.
Published on Thu 20 Feb 2025 7:52:47 UTC
SLOUGH, United Kingdom and RICHMOND, Va., Feb. 20, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending December 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.
EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN
Published on Thu 20 Feb 2025 7:52:29 UTC
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ -- Sobi and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli (pegcetacoplan) for the treatmentof C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN), which are rare, chronic kidney diseases with no approved treatments.
Published on Thu 20 Feb 2025 7:51:12 UTC
SOUL, Core du Sud, 20 fvrier 2025 /PRNewswire/ -- Coway Co. Ltd, la Best Life Solution Company, a officiellement lanc son plan d'amlioration de la valeur de l'entreprise, raffirmant son engagement en faveur de l'amlioration durable de la valeur actionnariale. Aprs avoir annonc le mois dernier l'augmentation de son taux de rendement total pour l'actionnaire de 20% 40%, Coway lance prsent des initiatives stratgiques supplmentaires visant renforcer la valeur de l'entreprise.
Published on Thu 20 Feb 2025 7:51:03 UTC
SEOUL, Zuid-Korea, 20 februari 2025 /PRNewswire/ -- Coway Co., Ltd., de "Best Life Solution Company", heeft officieel zijn "Corporate Value-Up Plan" gelanceerd, waarmee het bedrijf zijn inzet voor een duurzame verbetering van de aandeelhouderswaarde opnieuw bevestigt. Na de aankondiging vorige maand om het totale aandeelhoudersrendement te verhogen van 20% naar 40%, introduceert Coway nu aanvullende strategische initiatieven gericht op het vermeerderen van de bedrijfswaarde.
Published on Thu 20 Feb 2025 7:47:54 UTC
BRUSSELS, Feb. 20, 2025 /PRNewswire/ --Mars, Incorporated - the leading pet care business - has announced the launch of the Pets and Wellbeing Study (PAWS) program. PAWS is set to become the world's largest, multi-year research program exploring the impact of cats and dogs on mental health and wellbeing, deepening our understanding of the mutual benefits of the human-animal bond.
Published on Thu 20 Feb 2025 7:45:37 UTC
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced a strategic collaboration to accelerate the discovery and development of innovative therapeutic antibodies, leveraging their respective technological strengths in antibody discovery and artificial intelligence.
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities